Cellectar Biosciences

CLRB · NASDAQ

$1.23+$0.11 (+9.82%)TodayMarket closed ·
Prev close $1.12

Who owns CLRB

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 35.1% of CLRB’s shares.

  • Caligan Partners, LP5.9%
  • StemPoint Capital LP4.4%
  • Vanguard Capital Management, LLC4.1%
  • SilverArc Capital Management, LLC4.0%
  • Next 6 largest institutions16.7%
  • All other shareholders64.9%
Top institutional holders of CLRB
HolderShares% of shares
Caligan Partners, LP470.00K5.88%
StemPoint Capital LP354.94K4.44%
Vanguard Capital Management, LLC327.37K4.10%
SilverArc Capital Management, LLC321.73K4.03%
Bleichroeder LP288.68K3.61%
Janus Henderson Investors274.16K3.43%
Balyasny Asset Management LP220.00K2.75%
Nantahala Capital Management, LLC220.00K2.75%
Empery Asset Management, L.P.189.60K2.37%
Diadema Partners LP138.34K1.73%

Largest mutual fund holders

Top mutual fund holders of CLRB
HolderShares% of shares
Vanguard Total Stock Market Index Fund184.15K2.30%
Vanguard Extended Market Index Fund143.22K1.79%
Fidelity Extended Market Index Fund42.52K0.53%
Abante Quant Value, FI18.06K0.23%
Fidelity Series Total Market Index Fund5.64K0.07%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $50.52K (4 trades) of CLRB on the open market, with no sales.

Latest CLRB insider transactions
InsiderTypeSharesValue
Loren StefanAward15.00K—
Loren StefanAward15.00K—
Kolean Chad JAward92.00K—
Chanan-Khan AsherAward25.00K—
Gu AndrewAward25.00K—
Longcor JarrodAward118.00K—
Swirsky Douglas JAward37.50K—
CARUSO JAMES VAward250.00K—
NEIS JOHNAward25.00K—
DRISCOLL FREDERICK WAward25.00K—

Short interest

Settled Sep 30, 2026

Shares short
166.26K
Days to cover
2.05
% of shares outstanding
2.08%
Average daily volume
81.29K
Change since last report
−13.0%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.